Prot #CLS1001-201: A Randomized, Masked, Multicenter Study to Assess the Safety and Efficacy of CLS-TA, Triamcinolone Acetonide Injectable Suspension in the Treatment of Subjects with Macular Edema Following Uveitis

Project: Research project

Project Details

StatusFinished
Effective start/end date1/6/151/6/18

Funding

  • PPD Development (Prot #CLS1001-201 // Prot #CLS1001-201)
  • Clearside Biomedical, Inc (Prot #CLS1001-201 // Prot #CLS1001-201)